Cargando…
Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities.
Autores principales: | Guchelaar, H. J., Hoekstra, H. J., de Vries, E. G., Uges, D. R., Oosterhuis, J. W., Schraffordt Koops, H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977776/ https://www.ncbi.nlm.nih.gov/pubmed/1319729 |
Ejemplares similares
-
Hyperthermic Isolated Limb Perfusion with TNF α
and Cisplatin in the
Treatment of Osteosarcoma of the Extremities: A Feasibility Study in
Healthy Dogs
por: Van Ginkel, Robert J., et al.
Publicado: (1999) -
Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells.
por: Hettinga, J. V., et al.
Publicado: (1997) -
Regional Therapy for Recurrent Metastatic Melanoma Confined to the Extremity: Hyperthermic Isolated Limb Perfusion vs. Isolated Limb Infusion
por: Reintgen, Michael, et al.
Publicado: (2010) -
Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities
por: Farzaliyev, Farhad, et al.
Publicado: (2020) -
A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.
por: Gietema, J. A., et al.
Publicado: (1993)